Illumina Accelerator Invests in Nine Genomics Startups for Second Global CycleBusiness Wire • 02/08/21
Week In Review: Junshi Signs $1.1 Billion Deal For U.S.-Canada Rights To PD-1Seeking Alpha • 02/07/21
Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across BelgiumBusiness Wire • 02/04/21
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in ChinaBusiness Wire • 02/01/21
Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021Business Wire • 01/25/21
Illumina, Inc. (ILMN) CEO Francis deSouza Presents at J.P. Morgan 39th Annual Healthcare Conference (Transcript)Seeking Alpha • 01/12/21
Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic ProfilingBusiness Wire • 01/11/21
Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance InfrastructureBusiness Wire • 01/06/21